Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2311-2319

  Swart, Jennifer M ^a   Bergeron, Daniele M ^a   Chiles, Thomas C ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; B LYMPHOCYTE RECEPTOR; CELL SURFACE IMMUNOGLOBULIN; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0034162494     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2311     Document Type: Article

References (63)

1. Scott, D. W. 1993. Analysis of B cell tolerance in vitro. Adv. Immunol. 54:393.
2. Nossal, G. J. V. 1983. Cellular mechanisms of immunologic tolerance. Annu. Rev. Immunol. 1:33.
3. 1 phase of the cell cycle in response to antigen receptor signaling. J. Immunol. 156:4562.
4. Campbell, K. S. 1999. Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol 11:256.
5. Birkeland, M. L., and J. G. Monroe. 1997. Biochemistry of antigen receptor signaling in mature and developing B lymphocytes. Crit. Rev. Immunol. 17:353.
6. Gold, M. R., J. S. Sanghera, J. Stewart, and S. L. Pelech. 1992. Selective activation of p42 MAP kinase in murine B lymphoma cell lines by membrane immunoglobulin crosslinking: evidence for protein kinase C-dependent and -independent mechanisms of activation. Biochem. J. 287:269.
7. Chen, Z. Z., K. M. Coggeshall, and J. C. Cambier. 1986. Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes. J. Immunol. 136:2300.
8. Hempel, W. M., R. C. Schatzman, and A. L. DeFranco. 1992. Tyrosine phosphorylation of phospholipase C-γ2 upon crosslinking of membrane Ig on murine B lymphocytes. J. Immunol. 148:3021.
9. Mittelstadt, P. R., and A. L. DeFranco. 1993. Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J. Immunol. 150:4822.
10. Solvason, N., W. W. Wu, N. Kabra, X. Wu, E. Lees, and M. C. Howard. 1996. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes. J. Exp. Med. 184:407.
11. Klemsz, M. J., L. B. Justement, E. Palmer, and J. C. Cambier. 1989. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 143:1032.
12. Seyfert, V. L., S. McMahon, W. Glenn, X. Cao, V. P. Sukhatme, and J. G. Monroe. 1990. Egr-1 expression in surface Ig-mediated B cell activation: kinetics and association with protein kinase C activation. J. Immunol. 145:3647.
13. Chiles, T. C., and T. L. Rothstein. 1992. Surface Ig receptor-induced nuclear AP-1-dependent gene expression in B lymphocytes. J. Immunol. 149:825.
14. Fisher, C. L., J. Ghysdael, and J. C. Cambier. 1991. Ligation of membrane Ig leads to calcium-mediated phosphorylation of the proto-oncogene product, Ets-1. J. Immunol. 146:1743.
15. 1 stage of the cell cycle. Cell Immunol. 158:96.
16. PSK-13/cdk4) for the major D-type cyclin in mature B lymphocytes. J. Immunol. 156:539.
17. 1 cell cycle stage following delivery of complete versus partial activation stimuli. Mol. Immunol. 33:1139.
18. Pongubala, J. M. R., and M. L. Atchison. 1995. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin κ 3′ enhancer. J. Biol. Chem. 270:10304.
19. Amato, S. F., K. Nakajima, T. Hirano, and T. C. Chiles. 1996. Transcriptional regulation of the junB promoter in mature B lymphocytes: activation through a cyclic adenosine 3′,5′-monophospnate-like binding site. J. Immunol. 157:146.
20. Feuerstein, N., R. Firestein, N. Aiyar, H. Xiao, D. Murasko, and V. Cristofalo. 1996. Late induction of CREB/ATF binding and a concomitant increase in cAMP levels in T and B lymphocytes stimulated via the antigen receptor. J. Immunol. 156:4582.
21. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
22. Cox, P. M., and C. R. Goding. 1992. An ATF/CREB binding motif is required for aberrant constitutive expression of the MHC class II DR α promoter and activation by SV40 T-antigen. Nucleic Acids Res. 20:4881.
23. Wilson, B. E., E. Mochon, and L. M. Boxer. 1996. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol. 16:5546.
24. Hsueh, Y. P., and M. Z. Lai. 1995. Overexpression of activation transcriptional factor I in lymphomas and in activated lymphocytes. J. Immunol. 154:5675.
25. Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675.
26. Andrisani, O. M. 1999. CREB-mediated transcriptional control. Crit. Rev. Euk. Gene Exp. 9:19.
27. Klemm, D. J., W. J. Roesler, T. Boras, L. A. Colton, K. Felder, and J. E.-B. Reusch. 1997. Insulin stimulates cAMP-response element binding protein activity in HepG2 and 3T3-L1 cell lines. J. Biol. Chem. 273:917.
28. Pugazhenthi, S., T. Boras, D. O'Connor, M. K. Meintzer, K. A. Heidenreich, and J. E.-B. Reusch. 1999. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells: involvement of p38 mitogen-activated protein kinase-mediated pathway. J. Biol. Chem. 274:2829.
29. Xie, H., T. C. Chiles, and T. L. Rothstein. 1993. Induction of CREB activity via the surface Ig receptor B cells. J. Immunol. 151:1.
30. Amato, S. F., K. Nakajima, T. Hirano, and T. C. Chiles. 1997. Transcriptional regulation of the junB gene in B lymphocytes: role of protein kinase A and a membrane immunoglobulin-regulated protein phosphatase. J. Immunol. 159:4676.
31. Pennell, C. A., L. W. Arnold, P. M. Lutz, N. J. LoCascio, P. B. Willoughby, and G. Haughton. 1985. Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implication. Proc. Natl. Acad. Sci. USA 82:3799.
32. Pennell, C. A., and D. W. Scott. 1986. Lymphoma models for B cell activation and tolerance. IV Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur. J. Immunol. 16:1577.
33. Jin Kim, K., C. Kanellopoulos-Langevin, R. M. Menvin, D. H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549.
34. Tanguay, D. A., and T. C. Chiles. 1994. Cell cycle-specific induction of Cdk2 expression in B lymphocytes following antigen receptor cross-linking. Mol. Immunol. 31:643.
35. Stokoe, D., K. Engel, D. G. Campbell, P. Cohen and M. Gaestel. 1992. Identification of MAPKAP kinase-2 as a major enzyme responsible for the phosphorylation of small mammalian heat shock proteins. FEBS Lett. 313:307.
36. Stokoe, D., D. Campbell, S. Nakielny, H. Hidaka, S. J. Leevers, C. Marshall, and P. Cohen. 1992. MAPKAP kinase-2: a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11:3985.
37. Lee, H., M. Arsura, M. Wu, and G. E. Sonenshein. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1169.
38. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729.
39. Tan, Y., J. Rouse, A. Zhang, S. Cariati, P. Cohen, and M. Comb. 1996. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAPK and MAP-KAP kinase-2. EMBO J. 15:4629.
40. Schaeffer, H. J., and M. J. Weber. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:2435.
41. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. Gallagher, P. Young, and J. Lee. 1995. 58203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
42. Craxton, A., G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1998. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 161:3225.
43. Salmon, R. A., I. N. Foltz, P. R. Young, and J. W. Schrader. 1997. The p38 mitogen-activated protein kinase is activated by ligation of the T and B lymphocyte antigen receptors. Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J Immunol. 159:5309.
44. Sutherland, C. L., A. W. Heath, S. L. Pelech, P. R. Young, and M. R. Gold. 1996. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J. Immunol. 157:3381.
45. Graves, J. D., K. E. Draves, A. Craxton, E. G. Krebs, and E. A. Clark. 1998. A comparison of signaling requirement for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas. J. Immunol. 161:168.
46. Graves, J. D., K. E. Draves, A. Craxton, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1996. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93:13814.
47. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite out-growth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase A, N-[2-bromocinnamyl-amino)ethyl]-5-isoquinoline-sulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 256:5267.
48. van Dam, H., D. Wilheim, I. Herr, A. Steffen, P. Herrlich, and P. Angel. 1995. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1789.
49. Freshney, N. W., L. Rawlinson, F. Guesdon, E. Jone, S. Cowley, J. Hsuan, and J. Saklatvata. 1994. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039.
50. Ben-Levy, R., I. A. Leighton, Y. N. Doza, P. Alwood, N. Morrice, C. J. Marshall, and P. Cohen. 1995. Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO J. 14:5920.
51. Huo, L., and T. L. Rothstein. 1995. Receptor-specific induction of individual AP-1 components in B lymphocytes. J. Immunol. 154:3300.
52. Rouse, J., P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock protein. Cell 78:1027.
53. 2-terminal kinase, activation correlates with surface IgM-mediated apoptosis in the WEHI 231 B cell line. J. Immunol. 161:1637.
54. Shirakata, Y., K. Ishii, H. Yagita, K. Okumura, M. Taniguchi, and T. Takemori. 1999. Distinct subcellular localization and substrate specificity of extracellular signal-related kinase in B cells upon stimulation with IgM and CD40. J. Immunol. 163:6598.
55. Purkerson, J. M., and D. C. Parker. 1998. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. J. Immunol. 160:2121.
56. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270:7420.
57. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNutty, M. J. Blumenthal, J R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
58. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808.
59. Li, Y.-Y., M. Baccam, S. B. Waters, J. E. Pessin, G. A. Bishop, and G. A. Koretzky. 1996. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. J. Immunol. 157: 1440.
60. 2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 7:1297.
61. 2-terminal kinase, and p38 mitogen-activaled protein kinase activation by the B cell antigen receptor. J. Exp. Med. 188:1287.
62. Hazzalin, C. A., A. Cuenda, E. Cano, P. Cohen, and L. C. Mahadevan. 1997. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene 15:2321.
63. Beyaert, R., A. Cuenda, W. V. Berghe, S. Plaisance, J. C. Lee, G. Haegeman, P. Cohen, and W. Fiers. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J. 15:1914.